AeroLeads people directory · profile

Dan Cojocari, Ph.D. Email & Phone Number

Senior Scientist II, Oncology Discovery, Biology at AbbVie
Location: Los Angeles, California, United States 8 work roles 2 schools
1 work email found @abbott.com LinkedIn matched
✓ Verified Jun 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email d****@abbott.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
AbbVie
Role
Senior Scientist II, Oncology Discovery, Biology
Location
Los Angeles, California, United States
Company size
57013 employees

Who is Dan Cojocari, Ph.D.? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Dan Cojocari, Ph.D. is listed as Senior Scientist II, Oncology Discovery, Biology at AbbVie, a company with 57013 employees, based in Los Angeles, California, United States. AeroLeads shows a work email signal at abbott.com and a matched LinkedIn profile for Dan Cojocari, Ph.D..

Dan Cojocari, Ph.D. previously worked as Senior Scientist - Precision Medicine Oncology at Amgen and Senior Scientist I, Translational Oncology & Biomarkers at Abbvie. Dan Cojocari, Ph.D. holds Doctor Of Philosophy - Phd, Oncology & Cancer Biology, Dep. Of Medical Biophysics from University Of Toronto.

Company email context

Email format at AbbVie

This section adds company-level context without repeating Dan Cojocari, Ph.D.'s masked contact details.

*@abbott.com
68% confidence

AeroLeads found 1 current-domain work email signal for Dan Cojocari, Ph.D.. Compare company email patterns before reaching out.

View email format View company profile Management contacts
Profile bio

About Dan Cojocari, Ph.D.

Oncology drug discovery and biomarkers scientist with a mission to bring better therapies to cancer patients.• Led biology of several oncology discovery projects that transitioned through early discovery that could bring first-in-class targeted drugs to cancer patients.• Contributing team member to clinical-stage programs ABBV-621 (Eftozanermin alfa TRAIL agonist), ABBV-467 (MCL-1 small molecule inhibitor), Mirzotamab clezutoclax (ABBV-155) .• Discovered the mechanism of action for the BCL2 inhibitor Venetoclax + HMA drug combination used in the treatment of AML.• Identified novel drug combinations for venetoclax in leukemia (pevonedistat), resulting in the initiation of two Phase I clinical trials, and uncovering mechanism of resistance using data from completed trials.• Previous research published in Nature Cell Biology, Nature Materials, Nature Protocols, Clinical Cancer Research and presented at numerous international conferences. A reviewer for several journals. Contributed to the development of the TRACER device published in Nature Materials/Protocols• PhD in cancer biology from University of Toronto at Princess Margaret Hospital focusing on tumour hypoxia, autophagy, UPR signaling. Active member of the American Association for Cancer Research and American Society of Hematology.While I have a connection to Amgen, opinions are my own and do not represent Amgen's position.

Listed skills include Leadership, Cancer Research, Collaborative Problem Solving, Reverse Transcription Polymerase Chain Reaction, and 46 others.

Current workplace

Dan Cojocari, Ph.D.'s current company

Company context helps verify the profile and gives searchers a useful next step.

AbbVie
Abbvie
Senior Scientist II, Oncology Discovery, Biology
Los Angeles, CA, US
Website
abbvie.com
Employees
57013
AeroLeads page
Company profile
View company profile Email format
8 roles

Dan Cojocari, Ph.D. work experience

A career timeline built from the work history available for this profile.

Senior Scientist Ii, Oncology Discovery, Biology

Abbvie

Los Angeles, CA, US

Senior Scientist - Precision Medicine Oncology

Current
Amgen

Thousand Oaks, CA, US

Precision Medicine, Oncology Discovery Biomarkers

Nov 2023 - Present

Senior Scientist Ii, Oncology Discovery, Biology

Abbvie

North Chicago, Illinois, US

  • Leading novel target biology for 2 programs by defining patient settings & understanding molecular determinants of activity; supporting small molecule and ADC programs.
  • Leading discovery program/clinical PD/biomarker assay development in-house and through CROs.
  • Progressing the discovery pipeline, associated translational/clinical research, and in-licensing activities while enhancing internal/external visibility.
  • Contributing team member for clinical-stage programs ABBV-621 (Eftozanermin alfa TRAIL agonist), ABBV-467 (MCL-1 small molecule inhibitor).
  • Managing a research team of 3 FTEs, including cross-site.
Jul 2020 - Oct 2023

Senior Scientist I, Translational Oncology & Biomarkers

Abbvie

North Chicago, Illinois, US

  • Precision Medicine venetoclax translational biology team.
  • Venetoclax development: generated experimental data to inform upon the mechanism of clinical activity with 5-Aza in AML, published in CCR journal (2020), and pevonedistat/5-Aza, published in Haematologica (2021)
  • Venetoclax development: advanced novel clinical concepts with emerging therapies, including establishing academic collaborations.
  • Led the implementation of a "clinic-to-bench" philosophy for oncology discovery apoptosis targets' biology efforts.
  • Managed and established new academic and industry project collaborations.
Sep 2017 - Jul 2020

Doctoral Research Fellow

Princess Margaret Cancer Centre Research
  • Princess Margaret Cancer Center, Prof. Brad Wouters group http://www.wklab.org/
  • Published 6 original research manuscripts, 1 review article, including leading Nature journals.
  • $100,000 in university, provincial, and federal scholarships, and awards. cGPA: A
  • Selected to present work at 5 international conferences. Awarded travel funds.
  • Investigated the importance of the autophagy, UPR, antioxidant molecular pathways in pancreatic cancer cell survival in the hypoxic tumour microenvironment.
Jan 2010 - Dec 2016

Summer Research Assistant

University Health Network

Toronto, Ontario, CA

Role of Rb in myogenic differentiation

May 2009 - Sep 2009
Team & coworkers

Colleagues at AbbVie

Other employees you can reach at abbvie.com. View company contacts for 57013 employees →

VK Vindhya Kakarla Vindhya Kakarla Colleague at AbbvieGreater Chicago Area, United States View → JK Jade Koska Jade Koska Colleague at AbbvieGreater Annecy Area, France View → DR D. Robin Shapiro D. Robin Shapiro Colleague at AbbvieGreater Chicago Area, United States View → PS Polina Stolyar Polina Stolyar Colleague at AbbvieCambridge, Massachusetts, United States, United States View → KO Ku’Uleialohamae’Ole Osako Ku’Uleialohamae’Ole Osako Colleague at AbbvieCosta Mesa, California, United States, United States View → MH Marina Hannon, Cpa Marina Hannon, Cpa Colleague at AbbvieGreater Chicago Area, United States View → RA Romane Auffret Romane Auffret Colleague at AbbvieCôtes d'Armor, Brittany, France, France View → MM Michael Mullarkey Michael Mullarkey Colleague at AbbvieWestport, County Mayo, Ireland, Ireland View → MU Mehmet Uzun Mehmet Uzun Colleague at AbbvieTrabzon, Türkiye, Turkey View → AC Andrei Cristian Anton Andrei Cristian Anton Colleague at AbbvieAprilia, Latium, Italy, Italy View →
2 education records

Dan Cojocari, Ph.D. education

Doctor Of Philosophy - Phd, Oncology & Cancer Biology, Dep. Of Medical Biophysics

University Of Toronto

Honours Bachelor Of Science With Distinction, Pharmaceutical Chemistry Specialist, Dep. Of Pharmaceutical Sciences

University Of Toronto
FAQ

Frequently asked questions about Dan Cojocari, Ph.D.

Quick answers generated from the profile data available on this page.

What company does Dan Cojocari, Ph.D. work for?

Dan Cojocari, Ph.D. works for AbbVie.

What is Dan Cojocari, Ph.D.'s role at AbbVie?

Dan Cojocari, Ph.D. is listed as Senior Scientist II, Oncology Discovery, Biology at AbbVie.

What is Dan Cojocari, Ph.D.'s email address?

AeroLeads has found 1 work email signal at @abbott.com for Dan Cojocari, Ph.D. at AbbVie.

Where is Dan Cojocari, Ph.D. based?

Dan Cojocari, Ph.D. is based in Los Angeles, California, United States while working with AbbVie.

What companies has Dan Cojocari, Ph.D. worked for?

Dan Cojocari, Ph.D. has worked for Abbvie, Amgen, Princess Margaret Cancer Centre Research, University Health Network, and Leslie Dan Faculty Of Pharmacy, University Of Toronto.

Who are Dan Cojocari, Ph.D.'s colleagues at AbbVie?

Dan Cojocari, Ph.D.'s colleagues at AbbVie include Vindhya Kakarla, Jade Koska, D. Robin Shapiro, Polina Stolyar, and Ku’Uleialohamae’Ole Osako.

How can I contact Dan Cojocari, Ph.D.?

You can use AeroLeads to view verified contact signals for Dan Cojocari, Ph.D. at AbbVie, including work email, phone, and LinkedIn data when available.

What schools did Dan Cojocari, Ph.D. attend?

Dan Cojocari, Ph.D. holds Doctor Of Philosophy - Phd, Oncology & Cancer Biology, Dep. Of Medical Biophysics from University Of Toronto.

What skills is Dan Cojocari, Ph.D. known for?

Dan Cojocari, Ph.D. is listed with skills including Leadership, Cancer Research, Collaborative Problem Solving, Reverse Transcription Polymerase Chain Reaction, Research And Development, Cell Biology, Xenografts, and Elisa.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.